European Perspective on Biosimilars
J Oncol Pract
.
2017 Sep;13(9_suppl):15s-16s.
doi: 10.1200/JOP.2017.025569.
Author
Håkan Mellstedt
1
Affiliation
1
Karolinska Institute, Solna, Stockholm, Sweden.
PMID:
28898594
DOI:
10.1200/JOP.2017.025569
No abstract available
MeSH terms
Antibodies, Monoclonal
Biological Products*
Biosimilar Pharmaceuticals*
Drug Utilization
Europe
Hematinics
Substances
Antibodies, Monoclonal
Biological Products
Biosimilar Pharmaceuticals
Hematinics